TJX adds to board
The TJX Companies has announced the appointment of Charles Wagner, Jr. to its board of directors, effective immediately.
Wagner is executive vice president and chief financial officer of Vertex Pharmaceuticals, Inc., a role he has served in since 2019. In this role, he oversees a range of functions for Vertex including accounting, finance, internal audit, investor relations, business development, and global security and facilities functions.
From 2015 until 2019, Wagner previously served as executive vice president, finance and CFO at Ortho Clinical Diagnostics, which he joined after serving in several senior financial roles in the life sciences and other industries.
“We are delighted to have Charlie join TJX as the newest member of our board of directors. He brings long and extensive corporate finance and enterprise-wide experience and expertise, including more than a decade in public and private company CFO roles, and refreshes our Board composition,” said Carol Meyrowitz, executive chairman of the board of The TJX Companies.
“We are pleased that Charlie’s deep financial knowledge complements the wide-ranging experience among our existing Directors, all of which is important to the oversight of our complex, global business. We look forward to working with Charlie as we continue to focus on the near- and long-term successful growth of our great company.”
In February this year, the U.S.-based off-price apparel and lifestyle retail company said 2023 is likely to see a strong growth in annual sales as inflation pushes bargain-hungry but brand-conscious customers to off-price retailers offering cheaper deals and promotions.
